I have been a pulmonologist since 2018 and have been working at the Netherlands Cancer Institute since August 2021. The great thing about the Netherlands Cancer Institute is that patient care and scientific research are strongly intertwined, so that new treatment options are quickly available and can be deployed. In addition to my work as a pulmonologist, I conduct scientific research with the main aim of better predicting which patient will benefit from immunotherapy.
This translation was generated automatically based on information in Dutch. It has not been reviewed by a medical specialist. The purpose of this translation is to make our information accessible to non-Dutch speakers. However, this information should not be considered a substitute for medical advice from your treating physician. The Netherlands Cancer Institute cannot guarantee the accuracy of this translation. For medical questions or advice, please consult your physician.
We place cookies on our website to improve the user experience of our website. These cookies are essential for the proper functioning of our website.
Adjust preferences
Accept cookies!
nl